162705-07-9,MFCD00937446
Catalog No.:AA001TAC

162705-07-9 | (Z)-2-Methoxy-5-(3,4,5-trimethoxystyryl)aniline

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$125.00   $87.00
- +
1g
95%
in stock  
$357.00   $250.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA001TAC
Chemical Name:
(Z)-2-Methoxy-5-(3,4,5-trimethoxystyryl)aniline
CAS Number:
162705-07-9
Molecular Formula:
C18H21NO4
Molecular Weight:
315.3636
MDL Number:
MFCD00937446
SMILES:
COc1cc(/C=C\c2ccc(c(c2)N)OC)cc(c1OC)OC
Properties
Properties
 
BP:
496.377°C at 760 mmHg  
Form:
Solid  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
362  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
1  
Formal Charge:
0  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.4  

Downstream Synthesis Route

[1]EuropeanJournalofMedicinalChemistry,2018,vol.156,p.666-679

[2]ChineseChemicalLetters,2015,vol.26,p.993-999

[3]JournalofAgriculturalandFoodChemistry,2016,vol.64,p.746-751

[4]BioorganicandMedicinalChemistry,2016,vol.24,p.938-956

[5]JournalofMedicinalChemistry,2005,vol.48,p.4087-4099

[6]ChemMedChem,2017,vol.12,p.678-700

[7]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.2780-2784

[8]JournalofMedicinalChemistry,1998,vol.41,p.3022-3032

[9]BioorganicandMedicinalChemistry,2013,vol.21,p.1248-1256

[10]PolishJournalofChemistry,2009,vol.83,p.81-85

[11]BioorganicandMedicinalChemistry,2000,vol.8,p.2417-2425

[12]Patent:US6350777,2002,B2.Locationinpatent:Pagecolumn34-35

[13]BioorganicandMedicinalChemistry,2006,vol.14,p.3231-3244

[14]BioorganicandMedicinalChemistry,2014,vol.22,p.5155-5167

[15]ACSMedicinalChemistryLetters,2019,vol.10,p.1115-1121

162705-07-9   
(Z)-1-(3'-azido-4'-methoxyphenyl)-2-(3'',4'',5''-trimethoxyphenyl)ethene 

[1]BioorganicandMedicinalChemistry,2000,vol.8,p.2417-2425

[2]Patent:US6350777,2002,B2.Locationinpatent:Pagecolumn35

[1]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.3551-3554

[1]BioorganicandMedicinalChemistry,2016,vol.24,p.938-956

[2]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.6948-6951

[3]BioorganicandMedicinalChemistry,2006,vol.14,p.3231-3244

C18H19NO4 
  162705-07-9 

[1]TetrahedronLetters,2007,vol.48,p.7007-7010

[2]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.6948-6951

Literature

Title: Discovery of a potent tubulin polymerization inhibitor: synthesis and evaluation of water-soluble prodrugs of benzophenone analog.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Identification of CKD-516: a potent tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumors.

Journal: Journal of medicinal chemistry 20100909

Title: Synthesis and biological evaluation of combretastatin analogs as cell cycle inhibitors of the G1 to S transition in Saccharomyces cerevisiae.

Journal: Bioorganic & medicinal chemistry letters 20100501

Title: Synthesis and antitumor-evaluation of cyclopropyl-containing combretastatin analogs.

Journal: Bioorganic & medicinal chemistry letters 20091215

Title: Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.

Journal: Bioorganic & medicinal chemistry letters 20080915

Title: Synthesis and biological activity of fluorinated combretastatin analogues.

Journal: Journal of medicinal chemistry 20080508

Title: 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.

Journal: Journal of medicinal chemistry 20061019

Title: Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.

Journal: Journal of medicinal chemistry 20050616

Title: Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.

Journal: Journal of medicinal chemistry 20040520

Title: Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.

Journal: Journal of medicinal chemistry 20030213

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:162705-07-9 Molecular Formula|162705-07-9 MDL|162705-07-9 SMILES|162705-07-9 (Z)-2-Methoxy-5-(3,4,5-trimethoxystyryl)aniline
Catalog No.: AA001TAC
162705-07-9,MFCD00937446
162705-07-9 | (Z)-2-Methoxy-5-(3,4,5-trimethoxystyryl)aniline
Pack Size: 250mg
Purity: 95%
in stock
$125.00 $87.00
Pack Size: 1g
Purity: 95%
in stock
$357.00 $250.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA001TAC
Chemical Name: (Z)-2-Methoxy-5-(3,4,5-trimethoxystyryl)aniline
CAS Number: 162705-07-9
Molecular Formula: C18H21NO4
Molecular Weight: 315.3636
MDL Number: MFCD00937446
SMILES: COc1cc(/C=C\c2ccc(c(c2)N)OC)cc(c1OC)OC
Properties
BP: 496.377°C at 760 mmHg  
Form: Solid  
Storage: Inert atmosphere;2-8℃;  
Complexity: 362  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 1  
Formal Charge: 0  
Heavy Atom Count: 23  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 6  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.4  
Downstream Synthesis Route
162705-13-7    162705-07-9 

[1]EuropeanJournalofMedicinalChemistry,2018,vol.156,p.666-679

[2]ChineseChemicalLetters,2015,vol.26,p.993-999

[3]JournalofAgriculturalandFoodChemistry,2016,vol.64,p.746-751

[4]BioorganicandMedicinalChemistry,2016,vol.24,p.938-956

[5]JournalofMedicinalChemistry,2005,vol.48,p.4087-4099

[6]ChemMedChem,2017,vol.12,p.678-700

[7]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.2780-2784

[8]JournalofMedicinalChemistry,1998,vol.41,p.3022-3032

[9]BioorganicandMedicinalChemistry,2013,vol.21,p.1248-1256

[10]PolishJournalofChemistry,2009,vol.83,p.81-85

[11]BioorganicandMedicinalChemistry,2000,vol.8,p.2417-2425

[12]Patent:US6350777,2002,B2.Locationinpatent:Pagecolumn34-35

[13]BioorganicandMedicinalChemistry,2006,vol.14,p.3231-3244

[14]BioorganicandMedicinalChemistry,2014,vol.22,p.5155-5167

[15]ACSMedicinalChemistryLetters,2019,vol.10,p.1115-1121

162705-07-9   
(Z)-1-(3'-azido-4'-methoxyphenyl)-2-(3'',4'',5''-trimethoxyphenyl)ethene 

[1]BioorganicandMedicinalChemistry,2000,vol.8,p.2417-2425

[2]Patent:US6350777,2002,B2.Locationinpatent:Pagecolumn35

162705-07-9    107-07-3    863116-52-3 

[1]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.3551-3554

162705-07-9    171778-17-9    286463-65-8 

[1]BioorganicandMedicinalChemistry,2016,vol.24,p.938-956

[2]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.6948-6951

[3]BioorganicandMedicinalChemistry,2006,vol.14,p.3231-3244

C18H19NO4 
  162705-07-9 

[1]TetrahedronLetters,2007,vol.48,p.7007-7010

[2]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.6948-6951

Literature fold

Title: Discovery of a potent tubulin polymerization inhibitor: synthesis and evaluation of water-soluble prodrugs of benzophenone analog.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Identification of CKD-516: a potent tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumors.

Journal: Journal of medicinal chemistry20100909

Title: Synthesis and biological evaluation of combretastatin analogs as cell cycle inhibitors of the G1 to S transition in Saccharomyces cerevisiae.

Journal: Bioorganic & medicinal chemistry letters20100501

Title: Synthesis and antitumor-evaluation of cyclopropyl-containing combretastatin analogs.

Journal: Bioorganic & medicinal chemistry letters20091215

Title: Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.

Journal: Bioorganic & medicinal chemistry letters20080915

Title: Synthesis and biological activity of fluorinated combretastatin analogues.

Journal: Journal of medicinal chemistry20080508

Title: 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.

Journal: Journal of medicinal chemistry20061019

Title: Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.

Journal: Journal of medicinal chemistry20050616

Title: Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.

Journal: Journal of medicinal chemistry20040520

Title: Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.

Journal: Journal of medicinal chemistry20030213

Building Blocks More >
1630906-35-2
1630906-35-2
1,1-Difluoro-5-azaspiro[2.5]octane hydrochloride
AA001TMN | MFCD27987104
163277-80-3
163277-80-3
Ac-Thr(tBu)-OH
AA001TWJ | MFCD00236771
16363-53-4
16363-53-4
2-(4-Aminophenyl)benzo[d]oxazol-6-amine
AA001U84 | MFCD00451476
1638772-13-0
1638772-13-0
2-Chloro-5,7-dimethyl-7h-pyrrolo[2,3-d]pyrimidine
AA001UFS | MFCD27987637
1644-14-0
1644-14-0
6-Fluoroquinoxaline
AA001USJ | MFCD03094247
16495-67-3
16495-67-3
Benzenamine, 4-methoxy-N-(1-methylethyl)-
AA001V3V | MFCD00800379
1609403-17-9
1609403-17-9
3-Pyridinemethanol, 5-bromo-α,α-dimethyl-, hydrochloride (1:1)
AA001VG3 | MFCD28024784
16165-33-6
16165-33-6
Diundecylamine
AA001VPI | MFCD00026548
16536-48-4
16536-48-4
Ethanedioic acid, 1,2-bis(2,3,4,5,6-pentafluorophenyl) ester
AA001W0T | MFCD00143774
165807-05-6
165807-05-6
4-(Dimethoxymethyl)pyrimidin-2-ylamine
AA001WAB | MFCD05864792
Submit
© 2017 AA BLOCKS, INC. All rights reserved.